Clarithromycin Leading to Complete Remission in the First-Line Treatment of Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma.
Medical University Vienna, Vienna, Austria.
Barbara
B
Kiesewetter
Medical University Vienna, Vienna, Austria.
Julius
J
Lukas
Medical University Vienna, Vienna, Austria.
Andreas
A
Kuchar
Medical University Vienna, Vienna, Austria.
Marius E
ME
Mayerhoefer
Medical University Vienna, Vienna, Austria.
Leonhard
L
Müllauer
Medical University Vienna, Vienna, Austria markus.raderer@meduniwien.ac.at.
Markus
M
Raderer
D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D060828:Induction Chemotherapy; D007765:Lacrimal Apparatus / Q000473:pathology*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D009367:Neoplasm Staging; D009918:Orbital Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction; D013967:Thyroiditis, Autoimmune / Q000150:complications* / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D017291:Clarithromycin